PH26375A - 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids-7-[1H-pyrrol-3-YL]-substituted 3,5-dihydroxyheptanoic acids and their pharmaceutical preparation thereof - Google Patents

7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids-7-[1H-pyrrol-3-YL]-substituted 3,5-dihydroxyheptanoic acids and their pharmaceutical preparation thereof Download PDF

Info

Publication number
PH26375A
PH26375A PH37199A PH37199A PH26375A PH 26375 A PH26375 A PH 26375A PH 37199 A PH37199 A PH 37199A PH 37199 A PH37199 A PH 37199A PH 26375 A PH26375 A PH 26375A
Authority
PH
Philippines
Prior art keywords
fluorophenyl
formula
isopropyl
denotes
phenyl
Prior art date
Application number
PH37199A
Other languages
English (en)
Inventor
Heiner Jendralla
Gerhard Beck
Ekkehard Baader
Bela Kerekjarto
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH26375A publication Critical patent/PH26375A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH37199A 1987-07-10 1988-07-08 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids-7-[1H-pyrrol-3-YL]-substituted 3,5-dihydroxyheptanoic acids and their pharmaceutical preparation thereof PH26375A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873722806 DE3722806A1 (de) 1987-07-10 1987-07-10 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-hept-6-ensaeuren, 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-heptansaeuren, ihre entsprechenden (delta)-lactone und salze, verfahren zu ihrer herstellung ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte

Publications (1)

Publication Number Publication Date
PH26375A true PH26375A (en) 1992-06-01

Family

ID=6331291

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37199A PH26375A (en) 1987-07-10 1988-07-08 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids-7-[1H-pyrrol-3-YL]-substituted 3,5-dihydroxyheptanoic acids and their pharmaceutical preparation thereof

Country Status (19)

Country Link
US (1) US5055484A (no)
EP (1) EP0300249B1 (no)
JP (1) JPS6434959A (no)
KR (1) KR890002135A (no)
AT (1) ATE85324T1 (no)
AU (1) AU1888088A (no)
DE (2) DE3722806A1 (no)
DK (1) DK384288A (no)
ES (1) ES2043736T3 (no)
FI (1) FI883247A (no)
GR (1) GR3007611T3 (no)
HU (1) HU208672B (no)
IE (1) IE63205B1 (no)
IL (1) IL87036A0 (no)
NO (1) NO883072L (no)
NZ (1) NZ225342A (no)
PH (1) PH26375A (no)
PT (1) PT87927B (no)
ZA (1) ZA884918B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3826814A1 (de) * 1988-08-06 1990-02-08 Hoechst Ag Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
IT1237793B (it) * 1989-12-21 1993-06-17 Zambon Spa Composti attivi come inibitori dell'enzima hmg-coa reduttasi
US5128366A (en) * 1990-07-05 1992-07-07 Shinogi & Co., Ltd. Pyrrole derivatives
DE4243279A1 (de) * 1992-12-21 1994-06-23 Bayer Ag Substituierte Triole
US7250444B2 (en) * 2003-08-11 2007-07-31 Pfizer Inc. Pyrrole-based HMG-CoA reductase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928380A (en) * 1973-03-29 1975-12-23 Sterling Drug Inc 1,1{40 -Spirobis(cyclopenta-{8 4,5-c{9 pyrroles)
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
WO1987002662A2 (en) * 1985-10-25 1987-05-07 Sandoz Ag Heterocyclic analogs of mevalonolactone and derivatives thereof, processes for their production and their use as pharmaceuticals
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
NO881411L (no) * 1987-04-14 1988-10-17 Bayer Ag Substituerte pyrroler.

Also Published As

Publication number Publication date
PT87927B (pt) 1995-03-01
ZA884918B (en) 1989-01-18
PT87927A (pt) 1989-06-30
DK384288D0 (da) 1988-07-08
GR3007611T3 (no) 1993-08-31
DK384288A (da) 1989-01-11
NZ225342A (en) 1991-03-26
EP0300249A1 (de) 1989-01-25
DE3878067D1 (de) 1993-03-18
HU208672B (en) 1993-12-28
NO883072L (no) 1989-01-11
IE882097L (en) 1989-01-10
US5055484A (en) 1991-10-08
AU1888088A (en) 1989-01-12
ES2043736T3 (es) 1994-01-01
NO883072D0 (no) 1988-07-08
IE63205B1 (en) 1995-04-05
HUT48580A (en) 1989-06-28
KR890002135A (ko) 1989-04-08
FI883247A (fi) 1989-01-11
ATE85324T1 (de) 1993-02-15
EP0300249B1 (de) 1993-02-03
DE3722806A1 (de) 1989-01-19
FI883247A0 (fi) 1988-07-07
IL87036A0 (en) 1988-12-30
JPS6434959A (en) 1989-02-06

Similar Documents

Publication Publication Date Title
US6492406B1 (en) Pharmaceutically active compounds
EP0629602B1 (en) 3,4-Dihydroxychalcone derivatives
PH26375A (en) 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids-7-[1H-pyrrol-3-YL]-substituted 3,5-dihydroxyheptanoic acids and their pharmaceutical preparation thereof
EA029587B1 (ru) Пирролбензодиазепины и их конъюгаты
SA516371701B1 (ar) مركب ترايازين واستخدامه للأغراض الطبية
EP0125702A2 (en) Polycyclic aromatic compounds
EP0011928A1 (en) 3,5-Dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them
JPH07500605A (ja) 三置換テトラヒドロフラン抗真菌化合物
EP0745075A1 (en) 6-substituted mycophenolic and derivatives with immunosuppressive activity
DK157543B (da) Pyrazolanaloge af mevalonolacton og derivater deraf samt deres anvendelse
US7645749B2 (en) Sterol/stanol nitroderivatives and use thereof
AU595026B2 (en) 1,4-disubstituted piperazine derivatives, pharmaceutical compositions containing them and process for preparing same
US20110039877A1 (en) Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
US20120122943A1 (en) Melampomagnolide B Derivatives as Antileukemic and Cytotoxic Agents
US20230129160A1 (en) Processes for preparing triazole glycolate oxidase inhibitors
HUT72082A (en) Substituted triols, pharmaceutical compositions containing them and process for their production
US20110190333A1 (en) Dihydrotetrabenanzine for the treatment of anxiety
US9688651B2 (en) Geranyl geranyl acetone analogs and uses thereof
JP6442615B2 (ja) インドール酢酸コア構造を含む化合物とその応用
PH26675A (en) Pyrimidinyl substituted hydroxyacids lactones and esters and pharmaceutical compositions containing them
EP0189936A2 (en) Hyposensitivity compounds
Krishna et al. First stereoselective total synthesis of decytospolides A and B
SA06270126B1 (ar) أملاح ليسين احادية لمركباتازول
JP2955057B2 (ja) 新規なα−マンノシダーゼ及びフコシダーゼ阻害剤
US20220213080A1 (en) Piperlongumine-based compound and immuno regulator comprising the same